Patent details

EN | LT

Supplementary protection

LT - (Z)-2-ciano-3-hidroksi-but-2-eno rūgšties-(4'-trifluormetilfenil)-amido panaudojimas išsėtinės sklerozės gydymui

EN - USE OF (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4`-TRIFLUOROMETHYLPHENYL)-AMIDE FOR TREATING MULTIPLE SCLEROSIS

SPC
(11)	Number of the document	C 1381356
(68)	Number of the document	1381356
(21)	Application number for Supplementary Protection Certificate	PA 2014 004
(22)	Date of filing the application	2014-01-31
(41)	Date of publication of the application	2014-03-25
	Date of publication of SPC	2014-11-25
(24)	Date of coming into effect of SPC	2022-04-05

Applicant
(71)	Aventis Pharmaceuticals Inc., ,

Grantee
(73)	Sanofi-Aventis Deutschland GmbH, Brüningstrasse 50 , 65926 Frankfurt am Main, DE

Attorney or representative
(74)	Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT

Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93)	EU/1/13/838/001-005, 2013-08-26

Calculated date of expiry of the SPC
(94)	2027-04-05

Name of the product protected by the basic patent
(95)	Teriflunomidum

Last renewal fee
	Payment date	Validity (years)	Amount
	2025-03-05	4	347.00 EUR

Next renewal fee
	2026-04-05

Legal status
	SPC granted